Editors' Pick Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis. Börnsen L, Romme Christensen J, Ratzer R, Oturai A B, Sørensen P S, Søndergaard H B, Sellebjerg F PLoS One. 2012; 7(11):e47578. Epub 2012 Nov 30. PMID: 23226199. Abstract CommentRecommendBookmarkWatch